JW Pharmaceutical Corporation
KSC: 001060.KS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Korea Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Young-Sub Shin
- Employees
- 1,064
- Headquarters
- Seoul, South Korea
- IPO year
- 2005
- Market cap
- ₩703.2B
- Website
- https://www.jw-pharma.co.kr
Loading 001060…
Loading profile data…Frequently asked questions about 001060
What does JW Pharmaceutical Corporation (001060.KS) do?
JW Pharmaceutical Corporation develops, manufactures, and sells medicines and medical supplies in Japan and internationally. It offers products in the areas of cardiovascular, gastrointestinal, urinary, oral hypoglycemic, antibiotics, anti-fungal, Ob and Gy, renal, CNS, anti-anemic, respiratory, rheumatic arthritis, anticancer, anesthetic, antid...
Where does 001060.KS trade?
JW Pharmaceutical Corporation (001060.KS) trades on the Korea Exchange.
What sector is 001060.KS in?
JW Pharmaceutical Corporation (001060.KS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of JW Pharmaceutical Corporation?
Young-Sub Shin is the chief executive officer of JW Pharmaceutical Corporation (001060.KS).
Where is JW Pharmaceutical Corporation headquartered?
JW Pharmaceutical Corporation is headquartered in South Korea.
Does 001060.KS pay a dividend?
Yes — JW Pharmaceutical Corporation (001060.KS) paid a trailing twelve-month dividend of KRW 650.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 001060.KS go public?
JW Pharmaceutical Corporation (001060.KS) completed its initial public offering in 2005.